-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Community-acquired -X- _ B-Patient
pneumonia -X- _ I-Patient
( -X- _ I-Patient
CAP -X- _ I-Patient
) -X- _ I-Patient
requires -X- _ O
urgent -X- _ O
and -X- _ O
specific -X- _ O
antimicrobial -X- _ O
therapy. -X- _ O
However -X- _ O
, -X- _ O
the -X- _ O
causal -X- _ O
pathogen -X- _ O
is -X- _ O
typically -X- _ O
unknown -X- _ O
at -X- _ O
the -X- _ O
point -X- _ O
when -X- _ O
anti-infective -X- _ O
therapeutics -X- _ O
must -X- _ O
be -X- _ O
initiated. -X- _ O
Physicians -X- _ O
synthesize -X- _ O
information -X- _ O
from -X- _ O
diverse -X- _ O
data -X- _ O
streams -X- _ O
to -X- _ O
make -X- _ O
appropriate -X- _ O
decisions. -X- _ O
Artificial -X- _ B-Intervention
intelligence -X- _ I-Intervention
( -X- _ I-Intervention
AI -X- _ I-Intervention
) -X- _ I-Intervention
excels -X- _ O
at -X- _ O
finding -X- _ O
complex -X- _ O
relationships -X- _ O
in -X- _ O
large -X- _ O
volumes -X- _ O
of -X- _ O
data. -X- _ O
We -X- _ O
aimed -X- _ O
to -X- _ O
evaluate -X- _ O
the -X- _ O
abilities -X- _ O
of -X- _ O
experienced -X- _ O
physicians -X- _ B-Intervention
and -X- _ I-Intervention
AI -X- _ I-Intervention
to -X- _ O
answer -X- _ O
this -X- _ O
question -X- _ O
at -X- _ O
patient -X- _ O
admission -X- _ O
: -X- _ O
is -X- _ O
it -X- _ O
a -X- _ O
viral -X- _ O
or -X- _ O
a -X- _ O
bacterial -X- _ O
pneumonia -X- _ O
? -X- _ O
METHODS -X- _ O
: -X- _ O
We -X- _ O
included -X- _ O
patients -X- _ B-Patient
hospitalized -X- _ I-Patient
for -X- _ I-Patient
CAP -X- _ I-Patient
and -X- _ O
recorded -X- _ O
all -X- _ O
data -X- _ O
available -X- _ O
in -X- _ O
the -X- _ O
first -X- _ O
3-h -X- _ O
period -X- _ O
of -X- _ O
care -X- _ O
( -X- _ O
clinical -X- _ O
, -X- _ O
biological -X- _ O
and -X- _ O
radiological -X- _ O
information -X- _ O
) -X- _ O
. -X- _ O
For -X- _ O
this -X- _ O
proof-of-concept -X- _ O
investigation -X- _ O
, -X- _ O
we -X- _ O
decided -X- _ O
to -X- _ O
study -X- _ O
only -X- _ O
CAP -X- _ O
caused -X- _ O
by -X- _ O
a -X- _ O
singular -X- _ O
and -X- _ O
identified -X- _ O
pathogen. -X- _ O
We -X- _ O
built -X- _ O
a -X- _ O
machine -X- _ O
learning -X- _ O
model -X- _ O
prediction -X- _ O
using -X- _ O
all -X- _ O
collected -X- _ O
data. -X- _ O
Finally -X- _ O
, -X- _ O
an -X- _ O
independent -X- _ O
validation -X- _ O
set -X- _ O
of -X- _ O
samples -X- _ O
was -X- _ O
used -X- _ O
to -X- _ O
test -X- _ O
the -X- _ O
pathogen -X- _ O
prediction -X- _ O
performance -X- _ O
of -X- _ O
: -X- _ O
( -X- _ O
i -X- _ O
) -X- _ O
a -X- _ O
panel -X- _ O
of -X- _ O
three -X- _ O
experts -X- _ O
and -X- _ O
( -X- _ O
ii -X- _ O
) -X- _ O
the -X- _ O
AI -X- _ O
algorithm. -X- _ O
Both -X- _ O
were -X- _ O
blinded -X- _ O
regarding -X- _ O
the -X- _ O
final -X- _ O
microbial -X- _ O
diagnosis. -X- _ O
Positive -X- _ O
likelihood -X- _ O
ratio -X- _ O
( -X- _ O
LR -X- _ O
) -X- _ O
values -X- _ O
> -X- _ O
10 -X- _ O
and -X- _ O
negative -X- _ O
LR -X- _ O
values -X- _ O
< -X- _ O
0.1 -X- _ O
were -X- _ O
considered -X- _ O
clinically -X- _ O
relevant. -X- _ O
RESULTS -X- _ O
: -X- _ O
We -X- _ B-Outcome
included -X- _ I-Outcome
153 -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
CAP -X- _ I-Outcome
( -X- _ I-Outcome
70.6 -X- _ I-Outcome
% -X- _ I-Outcome
men -X- _ I-Outcome
; -X- _ I-Outcome
62 -X- _ I-Outcome
[ -X- _ I-Outcome
51–73 -X- _ I-Outcome
] -X- _ I-Outcome
years -X- _ I-Outcome
old -X- _ I-Outcome
; -X- _ I-Outcome
mean -X- _ I-Outcome
SAPSII -X- _ I-Outcome
, -X- _ I-Outcome
37 -X- _ I-Outcome
[ -X- _ I-Outcome
27–47 -X- _ I-Outcome
] -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
37 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
viral -X- _ I-Outcome
pneumonia -X- _ I-Outcome
, -X- _ I-Outcome
24 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
bacterial -X- _ I-Outcome
pneumonia -X- _ I-Outcome
, -X- _ I-Outcome
20 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
a -X- _ I-Outcome
co-infection -X- _ I-Outcome
and -X- _ I-Outcome
19 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
no -X- _ I-Outcome
identified -X- _ I-Outcome
respiratory -X- _ I-Outcome
pathogen. -X- _ I-Outcome
We -X- _ I-Outcome
performed -X- _ I-Outcome
the -X- _ I-Outcome
analysis -X- _ I-Outcome
on -X- _ I-Outcome
93 -X- _ I-Outcome
patients -X- _ I-Outcome
as -X- _ I-Outcome
co-pathogen -X- _ I-Outcome
and -X- _ I-Outcome
no-pathogen -X- _ I-Outcome
cases -X- _ I-Outcome
were -X- _ I-Outcome
excluded. -X- _ I-Outcome
The -X- _ I-Outcome
discriminant -X- _ I-Outcome
abilities -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
AI -X- _ I-Outcome
approach -X- _ I-Outcome
were -X- _ I-Outcome
low -X- _ I-Outcome
to -X- _ I-Outcome
moderate -X- _ I-Outcome
( -X- _ I-Outcome
LR+ -X- _ I-Outcome
= -X- _ I-Outcome
2.12 -X- _ I-Outcome
for -X- _ I-Outcome
viral -X- _ I-Outcome
and -X- _ I-Outcome
6.29 -X- _ I-Outcome
for -X- _ I-Outcome
bacterial -X- _ I-Outcome
pneumonia -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
discriminant -X- _ I-Outcome
abilities -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
experts -X- _ I-Outcome
were -X- _ I-Outcome
very -X- _ I-Outcome
low -X- _ I-Outcome
to -X- _ I-Outcome
low -X- _ I-Outcome
( -X- _ I-Outcome
LR+ -X- _ I-Outcome
= -X- _ I-Outcome
3.81 -X- _ I-Outcome
for -X- _ I-Outcome
viral -X- _ I-Outcome
and -X- _ I-Outcome
1.89 -X- _ I-Outcome
for -X- _ I-Outcome
bacterial -X- _ I-Outcome
pneumonia -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
CONCLUSION -X- _ O
: -X- _ O
Neither -X- _ B-Outcome
experts -X- _ I-Outcome
nor -X- _ I-Outcome
an -X- _ I-Outcome
AI -X- _ I-Outcome
algorithm -X- _ I-Outcome
can -X- _ I-Outcome
predict -X- _ I-Outcome
the -X- _ I-Outcome
microbial -X- _ I-Outcome
etiology -X- _ I-Outcome
of -X- _ I-Outcome
CAP -X- _ I-Outcome
within -X- _ O
the -X- _ O
first -X- _ O
hours -X- _ O
of -X- _ O
hospitalization -X- _ O
when -X- _ O
there -X- _ O
is -X- _ O
an -X- _ O
urgent -X- _ O
need -X- _ O
to -X- _ O
define -X- _ O
the -X- _ O
anti-infective -X- _ O
therapeutic -X- _ O
strategy -X- _ O
. -X- _ O

